Once-Daily "Extended" Formulation of Nevirapine Holds Up Well in 48-Week Study Results - The Body
Links shared publicly online about this topic.
- 872total visits
Once-Daily "Extended" Formulation of Nevirapine Holds Up Well in 48-Week Study Results - The Body
View full resource at thebody.com
Tags: HIV, AIDS, HIV Medication, STD, Viramune, Safety
Most Recently Shared on September 15, 2010 at 12:02 pm By:
Once-Daily "Extended" Formulation of Nevirapine Holds Up Well in 48-Week Study Results http://bit.ly/c54e4b #hiv #aids #viramune #ICAAC
Study of Once Daily Levemir (SOLVETM): Insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. - Khunti - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Study of Once Daily Levemir (SOLVETM): Insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. - Khunti - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 26, 2012 at 1:52 am By:
Study of Once Daily Levemir (SOLVETM): Insights into the timing of insulin initiation in people with poorly cont... http://t.co/BZudd2AK
Gastroenterology News - One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis |3966390
mdlinx.com — “Gastroenterology Medical Article: One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 10:41 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three... http://t.co/II8vCbWR #GI
Metformin side effects
diabetesforum.com — “Have been taking Metformin ER 500 mg once daily since October with no I'll effects. However, lately I've noticed that when I take it, about an hour later I have gas pains that last until just before” View full resource at diabetesforum.com
Most Recently Shared on March 21, 2012 at 11:27 pm By:
Have been taking Metformin ER 500 mg once daily since October with no I'll effects. However, lately I've noticed... http://t.co/HfH0VEtC
Infectious Disease News - Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy |3984254
mdlinx.com — “Infectious Disease Medical Article: Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance Therapy” View full resource at mdlinx.com
Most Recently Shared on March 20, 2012 at 4:40 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maint... http://t.co/1yeo2fwy #ID
Novartis launches once-daily COPD drug in US - NEWS - General articles - Pharmaceutical Industry - PMLiVE
pmlive.com — “Pharmaceutical Industry | NEWS | General | Novartis launches once-daily COPD drug in US - Arcapta Neohaler could be blockbuster if pharma company makes most of product’s combination potential | PMLiVE” View full resource at pmlive.com
Most Recently Shared on March 20, 2012 at 2:39 pm By:
eyeonfda Health Lawyer and Pharma
RT @dominic_tyer: RT @pmlivecom: Novartis launches once-daily #COPD drug in US http://t.co/TapSx5wV #pharma
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary disease - Drugs.com MedNews
drugs.com — “- Arcapta Neohaler is the only once-daily, 24-hour long-acting beta2-agonist approved for maintenance treatment of airflow obstruction in COPD patients Novartis” View full resource at drugs.com
Most Recently Shared on March 20, 2012 at 12:07 pm By:
Drugs and Devices OW OW Health
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary di... http://t.co/fZkiPS6X #drug
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment
news-medical.net — “Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 10:07 am By:
OrganizedWisdom COPD OW Health
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment: Novartis Pharmaceuticals Corporation to... http://t.co/c8Ld4yBK
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment
news-medical.net — “Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 6:39 am By:
Asthma News: Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment: Novartis Pharmaceuticals C... http://t.co/fD1L9Pfa
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: EAST HANOVER, N.J., March 19, 2012 /PRNewswire/ -- Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta™ Neohaler™ (indacaterol inhalation powder) 75 mcg is now available in the ...” View full resource at finance.yahoo.com
Most Recently Shared on March 19, 2012 at 9:41 pm By:
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary diseas... http://t.co/8ejHWYvT
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease - MarketWatch
marketwatch.com — “Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on March 19, 2012 at 9:20 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary dis... http://t.co/TDxSDBVI
Saline irrigation is effective for children with chronic rhinosinusitis - Related Stories - ANA SmartBrief
smartbrief.com — “Children with chronic rhinosinusitis who were given once-daily intranasal irrigation with isotonic saline showed significant improvements in quality of life measures within three weeks, a study found. Researchers said there were no significant differences between the saline alone group and the sali…” View full resource at smartbrief.com
Most Recently Shared on March 17, 2012 at 3:07 pm By:
Saline irrigation is effective for #children with chronic rhinosinusitis. #ENT #peds http://t.co/R09kzmgG
Defcort 30 Usage (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “My mom age 55 is suspected Interstitial Lung Disease and doctor prescribed the medicine Defcort 30 once daily after breakfast My question is that Is the medicine be perfectly OK for cure the patient ... Learn about and discuss Defcort 30 Usage at The People's Medicine Community. (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on March 17, 2012 at 10:35 am By:
" My mom age 55 is suspected Interstitial Lung Disease, and doctor prescribed the medicine Defcort 30 - once d http://t.co/YVZhfSqv
Saline irrigation is effective for children with chronic rhinosinusitis - Related Stories - AAP SmartBrief
smartbrief.com — “Children with chronic rhinosinusitis who were given once-daily intranasal irrigation with isotonic saline showed significant improvements in quality of life measures within three weeks, a study found. Researchers said there were no significant differences between the saline alone group and the sali…” View full resource at smartbrief.com
Most Recently Shared on March 15, 2012 at 8:48 pm By:
Clara Song Doctor, Pediatrician, and Physician
Saline irrigation is effective for children with chronic rhinosinusitis http://t.co/x758pzgL
New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Ingenol mebutate was proven efficacious with a once-daily application for only 2 or 3 days Today, the New England Journal of Medicine (NEJM)...” View full resource at bioportfolio.com
Most Recently Shared on March 15, 2012 at 12:03 am By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebu... http://t.co/4Xs6FEUj BioPortfolio News
Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump... - YouTube
youtube.com — “Dr. Ronnie Fass discusses his manuscript "Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazol...” View full resource at youtube.com
Most Recently Shared on March 12, 2012 at 8:04 pm By:
New CGH video abstract on maintenance of heartburn relief for GERD patients after step-down from twice-daily PPI http://t.co/ioWxuMSa
Advertisement
